DK1389122T3 - Forebyggelse af epitelcancer - Google Patents

Forebyggelse af epitelcancer

Info

Publication number
DK1389122T3
DK1389122T3 DK02759763.2T DK02759763T DK1389122T3 DK 1389122 T3 DK1389122 T3 DK 1389122T3 DK 02759763 T DK02759763 T DK 02759763T DK 1389122 T3 DK1389122 T3 DK 1389122T3
Authority
DK
Denmark
Prior art keywords
epithelial cancer
cancer
prostate
bladder
lung
Prior art date
Application number
DK02759763.2T
Other languages
English (en)
Inventor
Hans Henrik Raskov
Original Assignee
Colotech As
Hans Henrik Raskov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/825,891 external-priority patent/US6703380B2/en
Application filed by Colotech As, Hans Henrik Raskov filed Critical Colotech As
Application granted granted Critical
Publication of DK1389122T3 publication Critical patent/DK1389122T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK02759763.2T 2001-04-05 2002-04-05 Forebyggelse af epitelcancer DK1389122T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/825,891 US6703380B2 (en) 1999-09-29 2001-04-05 Prevention of cancer
PCT/DK2002/000231 WO2002080889A2 (en) 2001-04-05 2002-04-05 A combination dosage of a cyclooxygenase (cox) inhibitor, a vitamin d3 including analogues and metabolites thereof and/or calcium for prevention of epithelial cancer

Publications (1)

Publication Number Publication Date
DK1389122T3 true DK1389122T3 (da) 2010-02-01

Family

ID=25245159

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02759763.2T DK1389122T3 (da) 2001-04-05 2002-04-05 Forebyggelse af epitelcancer

Country Status (12)

Country Link
EP (1) EP1389122B1 (da)
AT (1) ATE444072T1 (da)
AU (1) AU2002338311B2 (da)
CA (1) CA2445940C (da)
DE (1) DE60233869D1 (da)
DK (1) DK1389122T3 (da)
ES (1) ES2334215T3 (da)
IS (1) IS6976A (da)
NO (1) NO20034381L (da)
NZ (1) NZ529104A (da)
PT (1) PT1389122E (da)
WO (1) WO2002080889A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20135701L (fi) * 2013-06-26 2014-12-27 Mas Metabolic Analytical Services Oy Farmaseuttisesti käyttökelpoinen ja turvallinen kombinaatio käytettäväksi merkittävien sairauksien hoidossa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
DK1220676T3 (da) * 1999-09-29 2005-09-05 Colotech As Forebyggelse af colorektal cancer

Also Published As

Publication number Publication date
NZ529104A (en) 2004-05-28
CA2445940C (en) 2010-08-24
NO20034381L (no) 2003-12-05
WO2002080889A3 (en) 2003-02-20
DE60233869D1 (de) 2009-11-12
IS6976A (is) 2003-10-03
ES2334215T3 (es) 2010-03-08
PT1389122E (pt) 2009-12-23
EP1389122B1 (en) 2009-09-30
CA2445940A1 (en) 2002-10-17
WO2002080889A2 (en) 2002-10-17
EP1389122A2 (en) 2004-02-18
NO20034381D0 (no) 2003-10-01
AU2002338311B2 (en) 2006-08-10
ATE444072T1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
MY127290A (en) New use of flibanserin
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
EA201690265A2 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
GT200500137A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis.
AR109263A2 (es) Composición que comprende moxidectina
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
BRPI0508333A (pt) uso de um composto de vitamina d, método de prevenir e/ou tratar cistite intersticial, formulação farmacêutica, composto de vitamina d, e, kit
DK1220676T3 (da) Forebyggelse af colorektal cancer
CL2004002030A1 (es) Uso de interferon y ribavirina porque sirve para preparar un medicamento para tratar infecciones virales; composicion farmaceutica que comprende interferon, ribavirina y opcionalmente antioxidante; kit y su uso para preparar un medicamento para trata
BRPI0415232A (pt) uso de xenÈnio com hipotermia para tratar asfixia neonatal
WO2005105135A8 (en) Il-6 for therapy or prevention of chemotherapy-induced neuropathy
BRPI0519006A2 (pt) uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos
DE602005023742D1 (de) Formulierung von 3-amino-8-(1-piperazinyl)-2h-1benzopyran-2-on mit verzögerter freisetzung
DK1389122T3 (da) Forebyggelse af epitelcancer
PA8624501A1 (es) Piperazinas derivadas de úrea para el tratamiento de la endometrosis
UY26945A1 (es) Alcanosulfonatos de fenoxifenilo
DK1490049T3 (da) Citalopram til behandling af forhöjet blodtryk
DE60309926D1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
DK1962822T3 (da) Terapi af maligne neoplasier
BRPI0516832A (pt) uso para alfa-simpatomiméticos com uma estrutura de 2-imidazolina
GT200400014A (es) Metodo de tratamiento con nelfinavir
CL2004000633A1 (es) Compuestos copolimeros, composicion farmaceutica que los contiene y procedimiento de preparacion, utiles en el tratamiento de enfermedades metabolicas oseas.
CL2007003284A1 (es) Composicion farmaceutica que comprende una asociacion de i) ciclobenzaprina, ii) aceclofenaco y opcionalmente iii) excipientes; y su uso para el tratamiento de enfermedades musculares dolorosas.
DOP2001000253A (es) Alcanosulfonatos de fenoxifenilo.